ELELYSO

Product NDC
0069-0106
Requested package NDC
0069-0106-01
11-digit product format
000690106
Labeler code
0069
Product ID
0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Taliglucerase alfa
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
BLA022458
Marketing category
BLA
Marketing start
2012-05-01
Substance
TALIGLUCERASE ALFA
Active strength
200 U/5mL
Pharmacologic classes
Glucosylceramidase [CS], Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
ELELYSO
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TALIGLUCERASE ALFA200 U/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0R4NLX88O4Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1292879Internal RxNorm lookup
1292881Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
fa3cbd5d-677c-4b19-9032-d9182cb69a83Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0069-0106-01ELELYSO5 mL in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,531
0069-0106-01ELELYSO1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,131

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0069-0106-01EA - Each0069-0106aa2aeb05-7d47-4259-b6e3-ff71b6107c3a12012-07-24

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0069-0106ELELYSO (TALIGLUCERASE ALFA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]30Current NDC, Legacy NDC, 2 package rows20250129_fa3cbd5d-677c-4b19-9032-d9182cb69a83.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ELELYSOTALIGLUCERASE ALFAPfizer Laboratories Div Pfizer Incfa3cbd5d-677c-4b19-9032-d9182cb69a832025-12-29Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA022458
ndc (package): 0069-0106-01
ndc (product): 0069-0106
ndc11 (package): 00069010601

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
022458Elelysotaliglucerase alfa351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1292881Elelyso 200 UNT InjectionPSNfa3cbd5d-677c-4b19-9032-d9182cb69a8331
1292879taliglucerase alfa 200 UNT InjectionPSNfa3cbd5d-677c-4b19-9032-d9182cb69a8331
1292881taliglucerase alfa 200 UNT Injection [Elelyso]SBDfa3cbd5d-677c-4b19-9032-d9182cb69a8331
1292879taliglucerase alfa 200 UNT InjectionSCDfa3cbd5d-677c-4b19-9032-d9182cb69a8331
1292881Elelyso 200 UNT InjectionSYfa3cbd5d-677c-4b19-9032-d9182cb69a8331

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0069-0106-01000690106011 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS2012-05-010000-00-00NoNoCurrent